AVAIL

HeartBeam Enters into Strategic Alliance Agreement with Samsung

Retrieved on: 
Tuesday, May 30, 2023
Cardiology, Software, Health, Artificial Intelligence, Medical Devices, Health Technology, Wearables, Mobile Technology, Technology, Heart, Partnership, Atrial fibrillation, Veterans Health Administration, Samsung, SAA, Veteran, Research, United States Department of Veterans Affairs, AVAIL, Patient, Physician, Knox, Samsung Galaxy, AF, Coronary artery disease, FDA, LTS, Halo, Mobile phone, Medical device, Pharmaceutical industry, Learning, Veterans' affairs

HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (VECG) platform intended for patient use at home, today announced that it has entered into a Strategic Alliance Agreement (SAA) with Samsung, extending the existing SAA between LIVMOR and Samsung.

Key Points: 
  • HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (VECG) platform intended for patient use at home, today announced that it has entered into a Strategic Alliance Agreement (SAA) with Samsung, extending the existing SAA between LIVMOR and Samsung.
  • Under the terms of the agreement, HeartBeam and Samsung will identify and define opportunities for collaboration, tapping the HeartBeam team's expertise and patented technology in the assessment and monitoring of cardiac symptoms.
  • “The goal of this partnership is to bring standard of care for cardiac diagnostic capabilities to patients by utilizing cutting edge technologies of both Samsung and HeartBeam,” said Branislav Vajdic, Ph.D., HeartBeam CEO and Founder.
  • We are excited that LIVMOR is now part of HeartBeam and look forward to continuing our successful collaboration.

ChenMed Featured in AVAIL The Journal Special Edition Celebrating John Maxwell's 75 Years of Life and Leadership

Retrieved on: 
Friday, December 16, 2022
IDG, Culture, Maxwell, Newsweek, Creativity, Life, Magic, Telehealth, Patient, AVAIL, Change the World, Consultant, Health care, CMO, Chief medical informatics officer, Journal, COVID-19, Future, Multimedia, Mortality, Health, DRS, Medicare, Computerworld, Management, Medicine, Pharmaceutical industry, Chenming Paper, Family

MIAMI, Dec. 16, 2022 /PRNewswire/ -- ChenMed, a leading primary care practice long focused on transforming care of the neediest populations, is featured in the Fall 2022 AVAIL The Journal special edition celebrating John Maxwell's 75 years of life and leadership. "The duty of care: how ChenMed is transforming the health industry with values-based service", article spotlights how and why ChenMed invests a lot of time and effort in leadership development. Plus, it describes how John Maxwell helped Drs. Christopher and Gordon Chen, ChenMed CEO and Chief Medical Officer, respectively, bring the magic of effective ministry into the business of health to transform care.

Key Points: 
  • Physician-led primary care leader advances mission by focusing on family, faith, and key Maxwell leadership principles
    MIAMI, Dec. 16, 2022 /PRNewswire/ -- ChenMed, a leading primary care practice long focused on transforming care of the neediest populations, is featured in the Fall 2022 AVAIL The Journal special edition celebrating John Maxwell's 75 years of life and leadership. "
  • The duty of care: how ChenMed is transforming the health industry with values-based service ", article spotlights how and why ChenMed invests a lot of time and effort in leadership development.
  • Christopher and Gordon Chen, ChenMed CEO and Chief Medical Officer, respectively, bring the magic of effective ministry into the business of health to transform care.
  • We stay focused on empowering servant leaders to do whatever it takes to transform care of the neediest populations.

Guidehouse Wins Prime Role on VA's $650M AVAIL Healthcare Innovation Contract, Including 4 of 5 Initial Tasks

Retrieved on: 
Monday, December 5, 2022
Veterans Health Administration, VHA, Government, Veritas Capital, AVAIL, Modern Healthcare, Public sector, Policy, KLAS, Caregiver, Growth, National Guard, Health, Organization, Health insurance, Veteran, Learning

WASHINGTON, Dec. 5, 2022 /PRNewswire/ -- Guidehouse, a leading global provider of consulting services to public sector and commercial clients, has been awarded a prime role on Accelerating VA Innovation and Learning (AVAIL), a U.S. Department of Veterans Affairs (VA) initiative focused on designing, testing, and scaling healthcare innovations to improve Veteran care. Guidehouse won 4 of 5 key task orders to help VA develop a digital twin solution to optimize its healthcare construction, design, and planning processes, and pilot innovative payment models to drive value in the areas of chronic conditions management, physical therapy care coordination, and in-home care delivery.

Key Points: 
  • "This effort aligns our powerful combination of innovative digital and data transformation, commercial healthcare, and public health expertise with our collective partner network, the type of collaboration and synergy that embodies why Guidehouse exists."
  • Ranked 2022's second-largest healthcare management consulting firm by Modern Healthcare, Guidehouse helps providers, government agencies, life sciences companies, employers, payers, and other organizations solve the industry's most complex challenges.
  • With 12 KLAS #1 rankings, the Guidehouse Health team integrates strategy and policy expertise with deep industry partnerships across the healthcare ecosystem to assist organizations with modernizing and innovating healthcare services, finances, and operations.
  • Guidehouse is a leading global provider of consulting services to the public sector and commercial markets, with broad capabilities in management, technology, and risk consulting.

Accenture Federal Services Awarded Prime Role on $650M Department of Veterans Affairs Healthcare Innovation Contract

Retrieved on: 
Monday, October 31, 2022
Software, Managed Care, Networks, Telemedicine, Virtual Medicine, Data Management, White House, Federal Government, Technology, Defense, Health Technology, Veterans, Health, Public Policy, Government, United States Department of Veterans Affairs, VHA, Multimedia, AVAIL, Artificial intelligence, Machine learning, Partnership, Solution, Signals intelligence operational platforms by nation, NYSE, AFS, LLP, Virtual Student Federal Service, Technology, Cabinet, Operation, Advanced technology, Caregiver, Department, Hospital, Learning, Accenture

Accenture Federal Services (AFS), a subsidiary of Accenture (NYSE: ACN), has earned a spot on a Department of Veterans Affairs (VHA) contract that will deliver innovative healthcare technology solutions that can be scaled into clinical production.

Key Points: 
  • Accenture Federal Services (AFS), a subsidiary of Accenture (NYSE: ACN), has earned a spot on a Department of Veterans Affairs (VHA) contract that will deliver innovative healthcare technology solutions that can be scaled into clinical production.
  • View the full release here: https://www.businesswire.com/news/home/20221031005101/en/
    Shawn Roman, VA Client Account Lead for Accenture Federal Services (Photo: Business Wire)
    The VHA is the largest integrated health care system in the United States and has long been a pioneer of healthcare innovation, said Shawn Roman, Accenture Federal Services VA Client Account Lead.
  • Accenture Federal Services will now compete for task orders on this five-year indefinite-delivery, indefinite quality contract vehicle.
  • Accenture Federal Services, a wholly owned subsidiary of Accenture LLP, is a U.S. company headquartered in Arlington, Virginia.

Iron Bow Technologies Selected to Support VA’s $650M Accelerating VA Innovation and Learning Program

Retrieved on: 
Tuesday, October 25, 2022
Technology, Other Technology, Public Policy, Government, Health Technology, Other Health, White House, Federal Government, Health, General Health, Artificial Intelligence, AVAIL, Government, Patient, Private sector, Program, Technology, Precision medicine, Iron, Industry, Health, Department, United States Department of Veterans Affairs, Solution, Hospital, Management, Veteran, Learning

The Accelerating VA Innovation and Learning (AVAIL) contract, with a value of $650M, was released under the Department of Veterans Affairs Office of Healthcare Innovation and Learning (OHIL).

Key Points: 
  • The Accelerating VA Innovation and Learning (AVAIL) contract, with a value of $650M, was released under the Department of Veterans Affairs Office of Healthcare Innovation and Learning (OHIL).
  • Iron Bow Healthcare Solutions attributes its demonstrated success developing and integrating emerging technologies in VA for over 12 years as one of the reasons for selection under the AVAIL program.
  • We are eager to expand our support of VAs mission through thoughtful innovation, said Angie Stevens, Chief Strategy Officer of Iron Bow Healthcare Solutions.
  • Iron Bow Healthcare Solutions is at the forefront of digital health transformation and continues to develop, implement, manage, manufacture, and support solutions across the care continuum.

Savara Reports Fourth Quarter / Year-End 2019 Financial Results and Provides Business Update

Retrieved on: 
Thursday, March 12, 2020
Health, Infectious diseases, Clinical trials, Research, Science, Pharmaceutical, Biotechnology, Goodwill, IMPALA, OPTIMA, AVAIL, Savara

Savara Inc. (Nasdaq: SVRA), an orphan lung disease company, today reported financial results for the fourth quarter and full year ending December 31, 2019 and provided a business update.

Key Points: 
  • Savara Inc. (Nasdaq: SVRA), an orphan lung disease company, today reported financial results for the fourth quarter and full year ending December 31, 2019 and provided a business update.
  • Savara's net loss for the fourth quarter of 2019 was $31.7 million, or $(0.72) per share, compared with a net loss of $10.5 million, or $(0.29) per share, for the fourth quarter of 2018.
  • Research and development expenses were $8.7 million for the fourth quarter of 2019, compared with $9.9 million for the fourth quarter of 2018.
  • Operating expenses for the fourth quarter of 2019 were approximately $31.5 million which included $19.4 million in noncash goodwill impairment charges.